Daniela Scribano

Dr. Daniela Scribano

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
Meysam SarsharMeysam Sarshar
Meysam Sarshar
Payam BehzadiPayam Behzadi
Payam Behzadi
Daniela ScribanoDaniela Scribano
Daniela Scribano
APAnna Teresa Palamara
Anna Teresa Palamara
Cecilia AmbrosiCecilia Ambrosi
Cecilia Ambrosi
Acinetobacter baumannii is regarded as a life-threatening pathogen associated with community-acquired and nosocomial infections, mainly pneumonia. The rise in the number of A. baumannii antibiotic-resistant strains reduces effective therapies and increases mortality. Bacterial comparative genomic studies have unraveled the innate and acquired virulence factors of A. baumannii. These virulence factors are involved in antibiotic resistance, environmental persistence, host-pathogen interactions, and immune evasion. Studies on host–pathogen interactions revealed that A. baumannii evolved different mechanisms to adhere to in order to invade host respiratory cells as well as evade the host immune system. In this review, we discuss current data on A. baumannii genetic features and virulence factors. An emphasis is given to the players in host–pathogen interaction in the respiratory tract. In addition, we report recent investigations into host defense systems using in vitro and in vivo models, providing new insights into the innate immune response to A. baumannii infections. Increasing our knowledge of A. baumannii pathogenesis may help the development of novel therapeutic strategies based on anti-adhesive, anti-virulence, and anti-cell to cell signaling pathways drugs.

10 July 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Meysam SarsharMeysam Sarshar
Meysam Sarshar
Payam BehzadiPayam Behzadi
Payam Behzadi
Cecilia AmbrosiCecilia Ambrosi
Cecilia Ambrosi
Carlo ZagagliaCarlo Zagaglia
Carlo Zagaglia
APAnna Teresa Palamara
Anna Teresa Palamara
Daniela ScribanoDaniela Scribano
Daniela Scribano
Chaperone-usher fimbrial adhesins are powerful weapons against the uropathogens that allow the establishment of urinary tract infections (UTIs). As the antibiotic therapeutic strategy has become less effective in the treatment of uropathogen-related UTIs, the anti-adhesive molecules active against fimbrial adhesins, key determinants of urovirulence, are attractive alternatives. The best-characterized bacterial adhesin is FimH, produced by uropathogenic Escherichia coli (UPEC). Hence, a number of high-affinity mono- and polyvalent mannose-based FimH antagonists, characterized by different bioavailabilities, have been reported. Given that antagonist affinities are firmly associated with the functional heterogeneities of different FimH variants, several FimH inhibitors have been developed using ligand-drug discovery strategies to generate high-affinity molecules for successful anti-adhesion therapy. As clinical trials have shown d-mannose’s efficacy in UTIs prevention, it is supposed that mannosides could be a first-in-class strategy not only for UTIs, but also to combat other Gram-negative bacterial infections. Therefore, the current review discusses valuable and effective FimH anti-adhesive molecules active against UTIs, from design and synthesis to in vitro and in vivo evaluations.

1 March 2017 in Cell Reports
Verified
Journal Article
Open access
LPLisa Perruzza
Lisa Perruzza
GGGiorgio Gargari
Giorgio Gargari
MPMichele Proietti
Michele Proietti
Bruno FossoBruno Fosso
Bruno Fosso
ADAnna Maria D’eRchia
Anna Maria D’eRchia
FGFABIO GRASSI
FABIO GRASSI
The ATP-gated ionotropic P2X7 receptor regulates T follicular helper (Tfh) cell abundance in the Peyer's patches (PPs) of the small intestine; deletion of P2rx7, encoding for P2X7, in Tfh cells results in enhanced IgA secretion and binding to commensal bacteria. Here, we show that Tfh cell activity is important for generating a diverse bacterial community in the gut and that sensing of microbiota-derived extracellular ATP via P2X7 promotes the generation of a proficient gut ecosystem for metabolic homeostasis. The results of this study indicate that Tfh cells play a role in host-microbiota mutualism beyond protecting the intestinal mucosa by induction of affinity-matured IgA and suggest that extracellular ATP constitutes an inter-kingdom signaling molecule important for selecting a beneficial microbial community for the host via P2X7-mediated regulation of B cell help.

16 January 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMichele Proietti
Michele Proietti
LPLisa Perruzza
Lisa Perruzza
Daniela ScribanoDaniela Scribano
Daniela Scribano
GPGiovanni Pellegrini
Giovanni Pellegrini
RDRocco D’aNtuono
Rocco D’aNtuono
FGFABIO GRASSI
FABIO GRASSI
T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. The mutualistic co-evolution of host and microbes led to the relative tolerance of host’s immune system towards commensal microorganisms. The ATP-gated ionotropic P2X7 receptor limits T follicular helper (Tfh) cells expansion and germinal center (GC) reaction in the PPs. Here we show that transient depletion of intestinal ATP can dramatically improve high-affinity IgA response against both live and inactivated oral vaccines. Ectopic expression of Shigella flexneri periplasmic ATP-diphosphohydrolase (apyrase) abolishes ATP release by bacteria and improves the specific IgA response against live oral vaccines. Antibody responses primed in the absence of intestinal extracellular ATP (eATP) also provide superior protection from enteropathogenic infection. Thus, modulation of eATP in the small intestine can affect high-affinity IgA response against gut colonizing bacteria.

22 June 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Arianna PompilioArianna Pompilio
Arianna Pompilio
Daniela ScribanoDaniela Scribano
Daniela Scribano
Meysam SarsharMeysam Sarshar
Meysam Sarshar
Giovanni Di BonaventuraGiovanni Di Bonaventura
Giovanni Di Bonaventura
APAnna Teresa Palamara
Anna Teresa Palamara
Cecilia AmbrosiCecilia Ambrosi
Cecilia Ambrosi
Bacterial biofilms are a serious public-health problem worldwide. In recent years, the rates of antibiotic-resistant Gram-negative bacteria associated with biofilm-forming activity have increased worrisomely, particularly among healthcare-associated pathogens. Acinetobacter baumannii is a critically opportunistic pathogen, due to the high rates of antibiotic resistant strains causing healthcare-acquired infections (HAIs). The clinical isolates of A. baumannii can form biofilms on both biotic and abiotic surfaces; hospital settings and medical devices are the ideal environments for A. baumannii biofilms, thereby representing the main source of patient infections. However, the paucity of therapeutic options poses major concerns for human health infections caused by A. baumannii strains. The increasing number of multidrug-resistant A. baumannii biofilm-forming isolates in association with the limited number of biofilm-eradicating treatments intensify the need for effective antibiofilm approaches. This review discusses the mechanisms used by this opportunistic pathogen to form biofilms, describes their clinical impact, and summarizes the current and emerging treatment options available, both to prevent their formation and to disrupt preformed A. baumannii biofilms.

1 January 2021 in Journal of Virological Methods
Verified
Journal Article
Open access
Cecilia AmbrosiCecilia Ambrosi
Cecilia Ambrosi
CPCarla Prezioso
Carla Prezioso
PCPaola Checconi
Paola Checconi
Daniela ScribanoDaniela Scribano
Daniela Scribano
Meysam SarsharMeysam Sarshar
Meysam Sarshar
DLDOLORES LIMONGI
DOLORES LIMONGI
• Alternative suitable methods to extract SARS-CoV-2 RNA should be taken into account to cope with the ongoing pandemic. • Extraction efficiencies of different viral RNA kit brands can be optimized for detection of SARS-CoV-2 genome. • The accuracy and performance of the Allplex 2019-nCoV assay can be further improved. • New optimized primer pairs for the N gene, considering its variability and stability, are highly recommended.